Neoadjuvant and Adjuvant Therapy for Extremity Soft Tissue Sarcomas
- 3 June 2005
- journal article
- review article
- Published by Elsevier BV in Hematology/Oncology Clinics of North America
- Vol. 19 (3), 489-500
- https://doi.org/10.1016/j.hoc.2005.03.003
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcomaAnnals of Oncology, 2004
- The Impact of Chemotherapy on the Survival of Patients With High-grade Primary Extremity LiposarcomaAnnals of Surgery, 2004
- Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomasCancer, 2002
- A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcomaEuropean Journal of Cancer, 2001
- Soft-tissue sarcoma of the thigh: Surgical margin influences local recurrence but not survival in 152 patientsActa Orthopaedica, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group RegisterEuropean Journal of Cancer, 2000
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma groupEuropean Journal of Cancer and Clinical Oncology, 1987
- Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II studyEuropean Journal of Cancer and Clinical Oncology, 1983